Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for depression recurrence in diabetes
NCT00374426Phase 4Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in major depressive disorder (MDD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 1998; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00374426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374426.